@article{ref1,
title="Two cases of zolpidem-associated homicide",
journal="Primary care companion to CNS disorders",
year="2012",
author="Paradis, Cheryl M. and Siegel, Lawrence A. and Kleinman, Stuart B.",
volume="14",
number="4",
pages="ePub-ePub",
abstract="Zolpidem is the most commonly prescribed medication for the short-term treatment of insomnia. Adverse reactions include nightmares, confusion, and memory deficits. Reported rare adverse neuropsychiatric reactions include sensory distortions such as hallucinations. Previous research has identified 4 factors that may place a patient at increased risk of zolpidem-associated psychotic or delirious reactions: (1) concomitant use of a selective serotonin reuptake inhibitor (SSRI), (2) female gender, (3) advanced age, and (4) zolpidem doses of 10 mg or higher. In this article, 2 cases are presented in which individuals killed their spouses and claimed total or partial amnesia. Neither individual had a history of aggressive behavior. Both had concomitantly taken 10 mg or more of zolpidem in addition to an SSRI (paroxetine).<p /> <p>Language: en</p>",
language="en",
issn="2155-7772",
doi="10.4088/PCC.12br01363",
url="http://dx.doi.org/10.4088/PCC.12br01363"
}